Why is Natco Pharma Ltd. ?
- The company has declared negative results for the last 2 consecutive quarters
- NET SALES(Q) At Rs 739.10 cr has Fallen at -35.2% (vs previous 4Q average)
- PBT LESS OI(Q) At Rs 66.30 cr has Fallen at -83.1% (vs previous 4Q average)
- PAT(Q) At Rs 267.90 cr has Fallen at -31.2% (vs previous 4Q average)
- Along with generating -3.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Natco Pharma for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 4.63 times
At Rs 739.10 cr has Fallen at -35.2% (vs previous 4Q average
At Rs 66.30 cr has Fallen at -83.1% (vs previous 4Q average
At Rs 267.90 cr has Fallen at -31.2% (vs previous 4Q average
Lowest at 15.37%
Lowest at 17.26%
Lowest at Rs 127.60 cr.
is 53.99 % of Profit Before Tax (PBT
Here's what is working for Natco Pharma
Debtors Turnover Ratio
Here's what is not working for Natco Pharma
Net Sales (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Profit to Sales
Operating Profit (Rs Cr)
PBT less Other Income (Rs Cr)
Non Operating Income to PBT






